Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 21, 2026
Approximately 5 minutes
Commercialization of Medical Devices in Spain – AEMPS Requirements
Commercialization of Medical Devices in Spain – AEMPS Requirements
EU-Wide Requirements for Market Placement
Medical devices intended to be placed on the Spanish market must comply with Regulation (EU) 2017/745 (MDR) or Regulation (EU) 2017/746 (IVDR) as applicable. Essential steps include:
- Successful conformity assessment leading to CE marking.
- Technical documentation, clinical evaluation/performance evaluation, and declaration of conformity.
- For higher-risk classes (IIa in some cases, IIb, III under MDR; B, C, D under IVDR), involvement of a notified body is mandatory.
- Manufacturers outside the EU must appoint an authorised representative established in the Union.
These requirements ensure devices meet essential safety and performance criteria before commercialization. Comercialización de productos sanitarios en España - AEMPS
National Obligations in Spain
In addition to EU rules, Spain imposes specific national requirements managed by AEMPS:
- Registro de Productos Sanitarios (RPS): Mandatory registration before placing on the market for Class I self-certified devices, custom-made devices, systems/procedure packs, and legacy devices during transitional periods (MDR Art. 120, IVDR Art. 110).
- Labelling and Instructions: Must be provided in Spanish for devices intended for lay users or when national law requires it. Minimum information includes UDI, manufacturer details, intended purpose, and warnings.
- Economic Operators Registration: Manufacturers, importers, and distributors must be registered in the corresponding national operator registry.
Non-compliance with national registration can prevent legal commercialization and lead to sanctions.
Vigilance and Post-Market Surveillance
Once commercialized, devices are subject to continuous monitoring:
- Serious incidents, field safety corrective actions, and trends must be reported promptly to AEMPS.
- Manufacturers maintain post-market surveillance systems, including periodic safety update reports where required.
- AEMPS coordinates vigilance activities, may request corrective measures, and collaborates with the EU network for rapid risk communication.
Practical Steps for Manufacturers and Distributors
- Complete CE marking and conformity assessment.
- Register in EUDAMED (mandatory for most devices).
- Fulfil Spanish RPS registration if applicable via the AEMPS portal.
- Ensure Spanish-language labelling and instructions as needed.
- Establish vigilance procedures and appoint a local responsible person if required.
AEMPS provides dedicated guidance, online registration tools, and updates on transitional arrangements to facilitate compliant commercialization. This dual EU-national framework balances harmonised safety standards with targeted national protections for the Spanish market. Comercialización de productos sanitarios en España - AEMPS
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Marketing and Placing on the Market of Medical Devices and IVDs in Spain
In Spain, medical devices and in vitro diagnostic medical devices (IVDs) must comply with EU MDR/IVDR requirements for marketing and placing on the market, including CE marking, registration in EUDAMED, Spanish national registration obligations during transitional periods, and vigilance reporting to AEMPS to ensure traceability and safety.
Approximately 5 minutes
Breast Implants Regulation and Vigilance in Spain – AEMPS Guidance
AEMPS maintains strict oversight of breast implants in Spain under EU MDR, requiring CE marking, manufacturer vigilance, annual reporting of ruptures and complications, patient registries, and rapid response to safety signals such as BIA-ALCL and other adverse events.